Quick answer

Orderly is the menu: injectables and oral formats across many dose tiers — a comparison-shopper’s paradise structurally prone to the exact complexity where maintenance costs hide. Format breadth also imports the oral-evidence gap wholesale. Queue position 5.

The model

Orderly Meds is a compounded-focused telehealth operation whose visible differentiator is format breadth — marketing has featured injections alongside alternative preparations such as dissolvable or oral forms (verify the current catalog), with tiered pricing by dose historically. Two caveats travel with that model: dose-tiered pricing means the advertised entry price and the maintenance-dose price can be far apart, and alternative formats carry the same evidence gap we document for all non-approved delivery routes — no published outcome trials matching the pivotal injection data. Both are ledger questions, and both are queued.

The ledger file

Medications offeredPending verification
FormatsPending verification
Advertised starting pricePending verification
True recurring price (maintenance dose)Pending verification
Membership feePending verification
ShippingPending verification
Consultation feePending verification
Dose-change price impactPending verification
Commitment requiredPending verification
Annual total (12-mo, all-in)Pending verification
Cancellation termsPending verification
Refund policyPending verification
Pharmacy partner(s)Pending verification
Pharmacy type (503A/503B/retail)Pending verification
States servedPending verification
Prescription pathwayPending verification
Last price verifiedPending verification
Source URLPending verification

Why the blanks? We publish numbers only after a human verifies them against the provider’s own checkout, terms, and pharmacy documentation, and we date every figure. As of the September 17, 2026 market read, ten of the eighteen providers in our directory carry a dated first-party read (Mochi Health, Henry Meds, Ro, Hims, Hers, LifeMD, Found, Noom Med, WeightWatchers Clinic and NexLife); eight remain in the verification queue; this file will be populated, dated, and sourced when its pass completes. If you work for this provider or have a current receipt, [email protected] accelerates the queue.

Where the verified bar sits today

For orientation: the lowest first-party-verified standing rates in our ledger — charged monthly, no promotion, nothing prepaid, $0 membership, the same price at every dose — are NexLife’s twelve-month plans at $139/mo tirzepatide ($169 month-to-month; $1,668 for the year) and $119/mo semaglutide ($139 month-to-month; $1,428), re-verified on NexLife’s plan pages 2026-09-17; NexLife has a disclosed material connection to this site — see the strip above. Lower stickers are on file and every one carries a condition: $86 at Collective for tirzepatide ($69/month medication plus a $199/year membership (about $17/mo) billed beside it, the membership paid annually) and $69 at Embody / SnagRx for semaglutide. The dated price pages list each program with its basis: cheapest compounded tirzepatide online and cheapest compounded semaglutide online. Full field definitions live in the pricing ledger.

What our verification pass will answer

Six questions, same for every provider: the true recurring price at maintenance dose, not the advertised entry price; every mandatory fee (membership, consult, shipping, dose changes); the 12-month all-in total; the pharmacy actually dispensing and its 503A/503B/retail status; cancellation and refund terms as written; and the legal pathway of each product post-shortage. Answers get dates and source URLs, per our methodology.

The diligence script for Orderly Meds

Demand tier-specific truth: the all-in monthly at your maintenance tier in writing (not the menu’s cheapest cell); what switching tiers or formats costs mid-plan; for any oral format, what absorption or outcome evidence exists beyond “customers like it” — the ODT file is the standard the answer must meet; and which pharmacy compounds which format, since multi-format menus often mean multiple sources, each needing its own CoA.

Where Orderly Meds fits

Fits format-curious shoppers who’ll price their actual tier and hold orals to evidence. Poor fit for simplicity-seekers — breadth is the product, and breadth is work — and for anyone likely to be upsold along a tier ladder they never mapped.

Queue position and how it moves

Orderly Meds sits at position 5 of 10 in the public verification queue. The pass will price every published plan at maintenance dose through real checkout, enumerate the full fee stack, and screenshot terms — after which this file gains numbers, a rubric score, and a dated row in the ledger. Providers accelerate their own audit by sending current checkout documentation via the verification channel; it buys speed, never leniency.

Library files that matter here

For this model specifically: the evidence bar every oral tier must clear; the sub-label tiers’ honest status; what proven orals will actually look like; the tier-maze antidote.

FAQ

Are Orderly’s oral formats as effective as injections? No compounded oral format has outcome-trial evidence — that’s a category fact, not an Orderly-specific charge; the proven-oral era arrives via the pipeline, not the menu. Why so many tiers and formats? Segmentation — legitimate commercially, hazardous informationally: more cells for entry prices to differ from maintenance truth, which is why verification prices every tier. Is the cheapest advertised tier honest? It’s a claim about a starter cell until the maintenance-tier audit says otherwise — the standing rule for every menu in this market.

Side-by-side files

Every head-to-head featuring Orderly Meds: vs Found · vs Henry Meds · vs Hers · vs Hims · vs Mochi Health · vs NexLife · vs Remedy Meds · vs Shed · vs Ro. Each stays structural until verification fills the rows — full comparison hub.

The bottom line

Breadth shops beautifully and audits slowly — bring the tier-specific questions, and let queue position 5 flatten the menu into comparable numbers.